BlackRock Global Funds Next Generation Healthcare A2 USD
Equity
Recent Price
Fund description
The Fund aims to provide a return on your investment through a combination of capital growth and income on the Fund’s assets. The Fund invests at least 80% of its total assets in the equity securities (i.e. shares) of companies globally that are involved with new and emerging themes in health care. In normal market conditions the Fund will invest in a portfolio of equity securities of companies with large, medium and small market capitalisation (i.e. the share price of the company multiplied by the number of shares readily available in the market) across multiple industries including (without limitation) biotechnology, pharmaceuticals, life sciences tools and services, health care technology, health care equipment, medical devices and digital health care, and across multiple subthemes including (without limitation) the following: genetic medicine, next generation diagnostics, immunotherapy, robotic-assisted surgery, biosensors and trackers, medical artificial intelligence applications and telehealth.The companies are evaluated by the Investment Adviser (IA) based on their ability to manage the risks and opportunities associated with the next generation health care theme and their ESG risk and opportunity credentials.
Fund Performance
Prices shown are indicative and are usually based on prices of 2-4 dealing days earlier, and may not be exactly the price used for individual trades. Prices and returns on this page may be based on a reference price in a different currency to that of the fund dealing price. Returns experienced by individual clients may differ from those shown below. Clients should not rely on these prices for decision making. Fund prices provided by third-parties. dollarDEX does not guarantee any prices or valuations shown, and accepts no responsibility for their accuracy.
Return
1 week
-0.12
1 month
-1.72
6 months
4.13
1 year
13.49
3 years
Since start *
4.76
Annualized Return %
1 week
1 month
6 months
1 year
13.49
3 years
since start *
3.34
Annual Volatility %
1 week
1 month
6 months
1 year
10.68
3 years
since start *
16.71
Sharpe ratio +
1 week
1 month
6 months
1 year
1.22
3 years
since start *
0.17
*Since start means from start of data available to dollarDEX and may not coincide with inception of fund.
Performance chart
Fund details
| Price frequency | Daily |
| Pricing basis | Forward |
| Dealing basis (subscriptions) What is this? | T+0 |
| Dealing basis (redemptions) What is this? | T+0 |
| Sector | Healthcare & life sciences |
| Asset class | Equity |
| Asset sub-class | Mixed |
| Region | Global Peer funds |
| Dividend distribution option | NA |
| Launch price | USD 10.00 |
| Price currency [1] | USD |
| Payment currency | SGD,USD |
| Investment type | Cash, SRS |
| Risk (volatility) What is this? | Medium High |
|
Fund annual management & service fee
[2] (built into daily pricing, check prospectus for details) |
1.500% |
| Latest bid/NAV price | USD 8.59 (11-Dec-2024) |
| Bid price changes from last available price | +0.12% |
| Benchmark | MSCI All Country World Index |
| Minimum initial investment | SGD 5,000 USD 5,000 |
| Minimum subsequent investment | SGD 1,000 USD 1,000 |
| Minimum RSP investment | SGD 100 USD 100 |
1 Usually same as fund dealing currency (refer to prospectus). Some funds have a SGD reference price used by Navigator.
2 Total of fixed annual management and service fees. Check fund prospectus for details including variable performance fees, if any, which may not be included here.